NEUPHORIA THERAPEUTICS INC. (NEUP)
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
WM Sets Date for Second Quarter 2026 Earnings Conference Call
Coppernico Metals Closes $5.5 Million LIFE Offering
ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND, INC. REPORTS SECOND QUARTER EARNINGS
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Fastenal Company Announces Conference Call to Review 2026 Second Quarter Earnings
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
InvenTrust Properties Corp. Announces Second Quarter 2026 Earnings Release and Conference Call Dates